Back to results
US 11,630,111 B2Granted
Method for quantifying anti-TNF antibodies
AssigneePromise Proteomics
InventorsDorothée Lebert, Guillaume Picard
Life of this patent
Estimating the term…
Abstract
The present invention relates to a method for quantifying an anti-TNF antibody in a sample of a human individual comprising a step of adding to a test sample which may contain therapeutic anti-TNF antibodies a known amount of two or more labeled forms of said anti-TNF antibodies.
Claims3
A kit for quantifying anti-TNF antibodies comprising two or more Stable Isotopically Labeled anti-TNF antibodies selected from a group consisting of Infliximab, Etanercept, Adalimumab, Certolizumab and Golimumab, wherein the two or more Stable Isotopically Labeled anti-TNF antibodies are whole antibodies.
Dependencies are inferred from the claim text.